Antibody-mediated delivery of therapeutics has been primarily limited to agents containing amine, alcohol or thiol functional groups. Now, an approach has been developed to create stable and bio-reversible prodrugs that mask ortho-quinones. Drug release requires both protease activation followed by acid-assisted elimination.
Your institute does not have access to this article
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Drago, J. Z., Modi, S. & Chandarlapaty, S. Nat. Rev. Clin. Oncol. 18, 327–344 (2021).
Staben, L. R. et al. Nat. Chem. 8, 1112–1119 (2016).
Kolakowski, R. V. et al. Angew. Chem. Int. Ed. 55, 7948–7951 (2016).
Dunsmore, L. et al. Nat. Chem. https://doi.org/10.1038/s41557-022-00964-7 (2022).
Chuprakov, S. et al. Bioconjug. Chem. 32, 746–754 (2021).
Gong, Q., Hu, J., Wang, P., Li, X. & Zhang, X. Eur. J. Med. Chem. 210, 112962 (2020).
Ma, X. et al. J. Control. Release 200, 201–211 (2015).
Lehar, S. M. et al. Nature 527, 323–328 (2015).
Gadd, A. J. R., Greco, F., Cobb, A. J. A. & Edwards, A. D. Bioconjug. Chem. 26, 1743–1752 (2015).
The author declares no competing interests.
About this article
Cite this article
Pillow, T. ortho-Quinone drugs go pro. Nat. Chem. 14, 719–720 (2022). https://doi.org/10.1038/s41557-022-00993-2